Stockreport

BioCardia to Participate in Cantor Fitzgerald’s Cell and Genetic Medicines Conference

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], today announced it will participate on a panel as a presenting company at Cantor [Read more]